Information Journal Paper
APA:
Copy. (2018). A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro. CANCER MEDICINE, 7(5), 2064-2077. SID. https://sid.ir/paper/764390/en
Vancouver:
Copy. A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro. CANCER MEDICINE[Internet]. 2018;7(5):2064-2077. Available from: https://sid.ir/paper/764390/en
IEEE:
Copy, “A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro,” CANCER MEDICINE, vol. 7, no. 5, pp. 2064–2077, 2018, [Online]. Available: https://sid.ir/paper/764390/en